Birnbaum, 1999, Pharmacoeconomics, 16, 1, 10.2165/00019053-199916010-00001
Ward, 1999, J Am Soc Nephrol, 10, 429, 10.1681/ASN.V102429
Concato, 22, NEngl J Med 20 Jun, 342, 1887, 10.1056/NEJM200006223422507
Benson, 22, N Engl J Med 2 Jun, 342, 1878, 10.1056/NEJM200006223422506
Jick, 2000, Arch Dermatol, 136, 1231, 10.1001/archderm.136.10.1231
Martel, 19, BMJ 200 Jan, 330, 230, 10.1136/bmj.38313.624352.8F
Quach, 2004, Br J Clin Pharmacol, 57, 500, 10.1111/j.1365-2125.2003.02019.x
Vanasse, 21, BMC Musculoskelet Disord 200 Jun, 6, 33, 10.1186/1471-2474-6-33
Bergh, 2001, J Natl Cancer Inst Monogr, 30, 103, 10.1093/oxfordjournals.jncimonographs.a003445
Walland, 2004, Clin Experiment Ophthalmol, 32, 590, 10.1111/j.1442-9071.2004.00908.x
Monnet, 29, J Antimicrob Chemother 2 Apr, 53, 1109, 10.1093/jac/dkh230
Rahme, 2001, Br J Clin Pharmacol, 52, 185, 10.1046/j.1365-2125.2001.00348.x
Gandjour, 2002, Diabet Med, 19, 594, 10.1046/j.1464-5491.2002.00763.x
Berto, 2000, Pharmacoeconomics, 17, 197, 10.2165/00019053-200017020-00008
Leong, 2004, Intern Med J, 34, 410, 10.1111/j.1445-5994.2004.00567.x
Bassi, 2004, Gut, 53, 1471, 10.1136/gut.2004.041616
Dedes, 2004, Pharmacoeconomics, 22, 435, 10.2165/00019053-200422070-00003
Mashiba, 2004, JInt Med Res, 32, 331
Wong, 2002, Ann Acad Med Singapore, 31, 3
Lindgren, 2002, Pharmacoeconomics, 20, 101, 10.2165/00019053-200220020-00003
Remak, 8, Br J Cancer 2 Jun, 91, 77, 10.1038/sj.bjc.6601890
Ash, 2000, Health Care Fin Rev, 21, 7
Clark, 1995, Med Care, 33, 783, 10.1097/00005650-199508000-00004
Deyo, 1992, JClin Epidemiol, 45, 613, 10.1016/0895-4356(92)90133-8
Gilmer, 2001, Med Car, 39, 1188, 10.1097/00005650-200111000-00006
Kronick, 2000, CDPS Health Care Fin Rev, 21, 29
Angrist, 1996, J Am Stat Assoc, 91, 444, 10.1080/01621459.1996.10476902
Crown, 1998, Stat Med, 17, 1943, 10.1002/(SICI)1097-0258(19980915)17:17<1943::AID-SIM885>3.0.CO;2-0
DAgostino, 1998, Stat Med, 17, 2265, 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
